AbCellera Biologics Inc. (ABCL) ownership: Top institutional holder: BAKER BROS. ADVISORS LP ($105.66M). Insider activity: Net Seller (4 buys, 16 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 30275938.00 | $105.66M | 2026-03-31 |
| Capital World Investors | 13361096.00 | $46.63M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 10562065.00 | $36.86M | 2026-03-31 |
| TD Waterhouse Canada Inc. | 9564659.00 | $33.57M | 2026-03-31 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 7575476.00 | $26.44M | 2026-03-31 |
| TWO SIGMA ADVISERS, LP | 4878000.00 | $16.68M | 2025-12-31 |
| UBS Group AG | 4209052.00 | $14.69M | 2026-03-31 |
| ArrowMark Colorado Holdings LLC | 4105095.00 | $14.33M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-05-14 |
Back to ABCL overview · ABCL earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.